Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate/Severe Asthma”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01673672
What this trial is testing

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

Who this might be right for
Moderate to Severe Allergic Asthma
Cytos Biotechnology AG 365
Not applicableLooking for participantsNCT07189806
What this trial is testing

Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma

Who this might be right for
Asthma (Diagnosis)
Hvivo 250
Not applicableLooking for participantsNCT05691218
What this trial is testing

Early High-flow Oxygen Therapy With nebuLized Beta-2-agonist Using a Vibrating Mesh for the Management of Moderate to Severe Asthma Exacerbation in the Emergency Department

Who this might be right for
Moderate Asthma ExacerbationSevere Asthma Exacerbation
Poitiers University Hospital 60
Large-scale testing (Phase 3)Study completedNCT00109187
What this trial is testing

An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g

Who this might be right for
Asthma
Genentech, Inc.
Not applicableStudy completedNCT01920529
What this trial is testing

Aerobic Exercise in Children With Moderate and Severe Asthma

Who this might be right for
Asthma
Instituto Materno Infantil Prof. Fernando Figueira 50
Not applicableStudy completedNCT00621829
What this trial is testing

Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms

Who this might be right for
Asthma
University of California, Davis 30
Testing effectiveness (Phase 2)Looking for participantsNCT07282886
What this trial is testing

VENTURI (VENTilation Using Respiratory Imaging)

Who this might be right for
Asthma
University of Alabama at Birmingham 20
Not applicableStudy completedNCT00937066
What this trial is testing

Cost-effectiveness Study of Symbicort as Maintenance and Reliever Therapy (SMART)

Who this might be right for
Asthma
AstraZeneca 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07403487
What this trial is testing

Phase II Trial of RC1416 Injection in Asthma

Who this might be right for
Moderate to Severe Asthma
Nanjing RegeneCore Biotech Co., Ltd. 195
Large-scale testing (Phase 3)Study completedNCT00862394
What this trial is testing

A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma

Who this might be right for
Asthma
Chiesi Farmaceutici S.p.A. 783
Testing effectiveness (Phase 2)Study completedNCT06102005
What this trial is testing

Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma

Who this might be right for
Asthma
Sanofi 685
Testing effectiveness (Phase 2)Study completedNCT05985694
What this trial is testing

AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma

Who this might be right for
Eosinophilic Asthma
Advagene Biopharma Co. Ltd. 40
Testing effectiveness (Phase 2)Looking for participantsNCT06977581
What this trial is testing

Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Who this might be right for
Asthma
Pfizer 252
Large-scale testing (Phase 3)Study completedNCT00565955
What this trial is testing

Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children

Who this might be right for
Bronchial Asthma
All India Institute of Medical Sciences 116
Testing effectiveness (Phase 2)Study completedNCT00406965
What this trial is testing

Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma

Who this might be right for
Allergic Asthma
Genentech, Inc. 50
Large-scale testing (Phase 3)Study completedNCT00393952
What this trial is testing

New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma

Who this might be right for
Asthma
SkyePharma AG 557
Post-approval studies (Phase 4)Study completedNCT01476059
What this trial is testing

Pediatric Study to Evaluate Treatment of Persistent Moderate or Severe Asthma With the Association Fluticasone 250 mcg/Dose and Salmeterol 50 mcg/Dose - ADERE PROJECT

Who this might be right for
Asthma
GlaxoSmithKline 472
Testing effectiveness (Phase 2)Looking for participantsNCT07219173
What this trial is testing

Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

Who this might be right for
Asthma
Eli Lilly and Company 531
Large-scale testing (Phase 3)UnknownNCT02033122
What this trial is testing

Effect of Aerobic Training in Moderate or Severe Asthmatic Patients

Who this might be right for
Asthma.
Instituto de Investigação em Imunologia 58
Testing effectiveness (Phase 2)Active Not RecruitingNCT07054034
What this trial is testing

Study of MG-ZG122 Humanized Monoclonal Antibody in Asthma Subjects

Who this might be right for
Bronchial Asthma
Shanghai Mabgeek Biotech.Co.Ltd 160
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation